BCC responds to updated Border Operating Model

9th October 2020

Commenting on the government’s updated Border Operating Model, published today, BCC Director of Trade Facilitation Liam Smyth said:

“Today’s announcement of a revised Border Operating Model provides some more of the detail that was missing from the version published less than 12 weeks ago. Duty deferment accounts and postponed VAT accounting will both help firms’ cashflow as we enter a period of huge change at our borders.

“However, as highlighted in our recent unanswered questions document, businesses still have many areas where they urgently need more certainty, such as how the border between Northern Ireland and Great Britain will operate, clear guidance on rules of origin, which will only be done by ramping up government engagement with business.

“With just over 80 days until the end of the transition period, the businesses that produce the £300bn of UK exports to the EU are desperate for news of a comprehensive free trade agreement that will provide jobs and future prosperity across the United Kingdom.”

You might also be interested in

Bruce & Butler Rebrands as Hawsons Data Protection & Cyber Security

Mon 7th September 2026

Data Protection & Cyber Security firm, Bruce & Butler, has announced that it will adopt the branding of Hawsons as part of a strategic decision to align the two firms under a single, established identity.

Budget Must Back Business, Cut Costs and Deliver Growth

Mon 7th September 2026

The British Chambers of Commerce (BCC) is calling on Chancellor, John Healey, to ‘Back Business, Cut Costs and Deliver Growth’ in his first Budget statement.

Business Energy Basics 11: How to procure energy more effectively

Fri 4th September 2026

Business energy procurement is a headache. It shouldn't have to be.

Wake Smith helps Sheffield-founded tech business secure second seed fundraise

Thu 3rd September 2026

Wake Smith Solicitors has helped Sheffield-founded tech business Siguru Ltd secure further funding to continue to develop its AI system for medical, legal, and regulatory affairs review in the pharmaceutical sector.